Literature DB >> 998727

Experimental induction of erythroblastemia using intravenous carbonyl iron particles.

M Tavassoli, J Bening, D Houchin, W H Crosby.   

Abstract

An experimental model is presented whereby erythroblastemia, the appearance of nucleated red cells in circulation, was induced reproducibly in rabbits by intravenous injection of 0.5 to 1 g/kg carbonyl iron particles (CIP). The phenomenon reached a peak in 24 to 48 hours and disappeared after a week. Erythroblastemia was associated with evidence for disseminated intravenous coagulation; both could be aborted by administration of heparin. Repeated injection of CIP was always followed by recurrence of erythroblastemia. For a period as long as 7 months, the animals tolerated repeated injections without evidence of lasting sequelae. Electron microscopic studies of marrow tissue indicated alterations in the red cell nuclei but no alterations in the endothelium of marrow sinuses into which the red cells migrate to reach the circulation. This model provides a means to study the mechanisms involved in nuclear elimination by mammalian red cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998727      PMCID: PMC2032564     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  4 in total

1.  Erythroblastemia.

Authors:  M Tavassoli
Journal:  West J Med       Date:  1975-03

2.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

3.  Bone marrow erythroclasia: the function of perisinal macrophages relative to the uptake of erythroid cells.

Authors:  M Tavassoli
Journal:  J Reticuloendothel Soc       Date:  1974-02

4.  Fate of the nucleus of the marrow erythroblast.

Authors:  M Tavassoli; W H Crosby
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.